Connor, Clark & Lunn Investment Management (CC&L)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $551K | Sell |
|
|||||
|
2025
Q1 | $250K | Sell |
|
|||||
|
2024
Q4 | $680K | Buy |
|
|||||
|
2024
Q3 | $846K | Buy |
|
|||||
|
2024
Q2 | $764K | Buy |
|
|||||
|
2024
Q1 | $536K | Buy |
|
|||||
|
2023
Q4 | $281K | Buy |
|
|||||
|
2023
Q3 | $293K | Sell |
|
|||||
|
2023
Q2 | $365K | Buy |
|
|||||
|
2023
Q1 | $315K | Buy |
|
|||||
|
2022
Q4 | $365K | Buy |
|
|||||
|
2022
Q3 | $34K | Sell |
|
|||||
|
2022
Q2 | $144K | Sell |
|
|||||
|
2022
Q1 | $908K | Buy |
|
|||||
|
2021
Q4 | $717K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $270K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $554K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $171K | Sell |
|
|||||
|
2013
Q4 | $566K | Buy |
|
|||||
|
2013
Q3 | $122K | Buy |
|